These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders. Saponaro F; Sestito S; Runfola M; Rapposelli S; Chiellini G Front Med (Lausanne); 2020; 7():331. PubMed ID: 32733906 [TBL] [Abstract][Full Text] [Related]
9. Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-β agonist. Taub R; Chiang E; Chabot-Blanchet M; Kelly MJ; Reeves RA; Guertin MC; Tardif JC Atherosclerosis; 2013 Oct; 230(2):373-80. PubMed ID: 24075770 [TBL] [Abstract][Full Text] [Related]
10. Thyroid Hormone Analogues: An Update. Zucchi R Thyroid; 2020 Aug; 30(8):1099-1105. PubMed ID: 32098589 [TBL] [Abstract][Full Text] [Related]
11. Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH). Luong XG; Stevens SK; Jekle A; Lin TI; Gupta K; Misner D; Chanda S; Mukherjee S; Williams C; Stoycheva A; Blatt LM; Beigelman LN; Symons JA; Raboisson P; McGowan D; Vandyck K; Deval J PLoS One; 2020; 15(12):e0240338. PubMed ID: 33306682 [TBL] [Abstract][Full Text] [Related]
12. Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index. Erion MD; Cable EE; Ito BR; Jiang H; Fujitaki JM; Finn PD; Zhang BH; Hou J; Boyer SH; van Poelje PD; Linemeyer DL Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15490-5. PubMed ID: 17878314 [TBL] [Abstract][Full Text] [Related]
13. Development of the thyroid hormone receptor beta-subtype agonist KB-141: a strategy for body weight reduction and lipid lowering with minimal cardiac side effects. Grover GJ; Mellstrom K; Malm J Cardiovasc Drug Rev; 2005; 23(2):133-48. PubMed ID: 16007230 [TBL] [Abstract][Full Text] [Related]
14. Cardiac specific effects of thyroid hormone analogues. Danzi S; Klein I Horm Metab Res; 2011 Oct; 43(11):737-42. PubMed ID: 22009366 [TBL] [Abstract][Full Text] [Related]
15. Potential Role of Thyroid Receptor β Agonists in the Treatment of Hyperlipidemia. Jakobsson T; Vedin LL; Parini P Drugs; 2017 Oct; 77(15):1613-1621. PubMed ID: 28865063 [TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of a novel series of [1-(4-hydroxy-benzyl)-1H-indol-5-yloxy]-acetic acid compounds as potent, selective, thyroid hormone receptor β agonists. Burkholder TP; Cunningham BE; Clayton JR; Lander PA; Brown ML; Doti RA; Durst GL; Montrose-Rafizadeh C; King C; Osborne HE; Amos RM; Zink RW; Stramm LE; Burris TP; Cardona G; Konkol DL; Reidy C; Christe ME; Genin MJ Bioorg Med Chem Lett; 2015 Apr; 25(7):1377-80. PubMed ID: 25752984 [TBL] [Abstract][Full Text] [Related]